EcoDrugPlus

Cyclin-Dependent Kinase 4

Ensembl ID : ENSCCRG00000080202
Gene Symbol: CDK4
1 Cross references
236 Possible Orthologues:

Cyclin-Dependent Kinase 5

Ensembl ID : ENSCCRG00000016113
Gene Symbol: CDK5
1 Cross references
167 Possible Orthologues:

Cyclin-Dependent Kinase 5

Ensembl ID : ENSCCRG00000016094
Gene Symbol: CDK5
1 Cross references
168 Possible Orthologues:

Cyclin-Dependent Kinase 6

Ensembl ID : ENSCCRG00000057262
Gene Symbol: CDK6
1 Cross references
198 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSCCRG00000032487
Gene Symbol: CDK7
1 Cross references
216 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSCCRG00000075825
Gene Symbol: CDK7
1 Cross references
216 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSCCRG00000076439
Gene Symbol: CDK9
1 Cross references
203 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSCCRG00000068084
Gene Symbol: CDK9
1 Cross references
204 Possible Orthologues:

Cytidine Deaminase A

Ensembl ID : ENSCCRG00000081555
Gene Symbol: CDAA
1 Cross references
157 Possible Orthologues:

Cytidine Deaminase A

Ensembl ID : ENSCCRG00000080631
Gene Symbol: CDAA
1 Cross references
156 Possible Orthologues:

Cytidine Deaminase B

Ensembl ID : ENSCCRG00000067398
Gene Symbol: CDAB
1 Cross references
197 Possible Orthologues:

Cytochrome P450, Family 17, Subfamily A, Polypeptide 1

Ensembl ID : ENSCCRG00000010022
Gene Symbol: CYP17A1
1 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).